Vice President, Clinical Operations

Pre-clinical and non-human study design and management by MSA

Tim Warneke brings to Mesa Science Associates over 20 years of pharmaceutical development experience. These experiences range across large (Ciba-Geigy and Abbott Laboratories) to mid-size (King Pharmaceuticals) pharmaceutical companies and the world’s largest contract research organization (Quintiles).

Mr. Warneke has leveraged his expert knowledge of the Code of Federal Regulations, ICH Guidelines, Good Clinical Practice, and Good Laboratory Practice to provide operational excellence in support of numerous INDs and NDAs throughout his career. Operationally focused, he has been responsible for clinical study conduct across all phases of pharmaceutical development from single-center studies to large multi-national clinical trials utilizing a wide array of therapeutic areas including:

Cardiology/Vascular Diseases, Dermatology, Devices, Endocrinology, Gastroenterology, Healthy Volunteers, Hepatology (Liver, Pancreatic, Gall Bladder), Infections and Infectious Diseases, Musculoskeletal, Nephrology, Neurology, Oncology, Orthopedics/Orthopedic Surgery, Pediatrics Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Vaccines

Mr. Warneke began his career at Northwestern University in the Department of Community Health and Preventive Medicine, coordinating the clinical activities of the landmark NHLBI funded CARDIA study from its initial year in 1983 to 1988.

MSA News

MesaGreen Announces Progress

K9MGP Seizure Program In July 2019, MesaGreen Pharmaceutical (MGP) entered into a research agreement with the University of Minnesota Schools…

Read More

MSA Intern Graduates

Mesa Science Associates is pleased to announce that Peyton Coady, a former intern at MSA will be graduating from James…

Read More

Progress During the Pandemic

Our surviving the Covid-19 experience has been an example of what having a great team can do for a company….

Read More